Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Jochen Weigt, Jörn M. Schattenberg et al.|Journal of Hepatology|2022Cited by 26
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimenAdolfo de Salazar, Eiko Schnaitmann, Julia Dietz et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 22
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, R. Zachoval, Christiana Graf et al.|JHEP Reports|2024Cited by 8